RAFAEL HOLDINGS, INC. Cash, Including Discontinued Operations
RAFAEL HOLDINGS, INC. (RFL) had Cash, Including Discontinued Operations of $19.00 thousand as of 2024-04-30, per its 10-Q filed 2024-06-14.
Financial Statements › Cash Flow › Cash
us-gaap:CashIncludingDiscontinuedOperations · last filed 2024-12-20
- 2024-04-30: Cash, Including Discontinued Operations $19.00K.
- 2023-07-31: Cash, Including Discontinued Operations $19.00K.
- 2023-01-31: Cash, Including Discontinued Operations $19.00K.
- 2022-10-31: Cash, Including Discontinued Operations $19.00K.
| Period end | Cash, Including Discontinued Operations |
|---|---|
| 2024-04-30 | $19.00K 10-Q · filed 2024-06-14 |
| 2023-07-31 | $19.00K 10-K/A · filed 2024-12-20 |
| 2023-01-31 | $19.00K 10-Q · filed 2024-03-14 |
| 2022-10-31 | $19.00K 10-Q · filed 2023-12-14 |
| 2022-07-31 | $2.00M 10-K · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |